KW-2450
- Generic Name
- KW-2450
- Drug Type
- Small Molecule
- Chemical Formula
- C28H29N5O3S
- CAS Number
- 904899-25-8
- Unique Ingredient Identifier
- RS6V91I0HT
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer
Phase 1
Terminated
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT01199367
- Locations
- 🇺🇸
Associates in Hematology-Oncology, Los Angeles, California, United States
🇺🇸Clinical Oncology Associates, Farmington Hills, Michigan, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT00921336
- Locations
- 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸University of Maryland Greenbaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Memorial Sloan Kettering, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath